N MekniinKodeOcrevus Zunovo™ approved by FDAOn September 13, 2024, Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the United States Food and Drug…Oct 2Oct 2
N MekniinKodeVorasidenib: A Revolutionary Advance in Brain Tumor TreatmentIn the realm of oncological innovation, the recent FDA approval of Vorasidenib (VORANIGO) on August 7, 2024, heralds a significant…Aug 30Aug 30